In industrialized countries cancer is the second major cause of death after cardio vascular diseases.
30 % of the global population is suffering from cancer during their life-time.
More than 50 % of cancer patients receive radiotherapy treatment.
Up to 15 % of the patients receiving Radio Therapy could profit from Proton Therapy. More than 150 clinical studies are in progress to demonstrate the benefit.
Calculated on the 8 Mio. inhabitants of Switzerland about 20’000 patients will be treated with radio therapy. Therefore up to 3’000 patients could benefit from Proton Therapy.